Correction: The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes (PLoS ONE)

Rebecca C. Coll, Luke A J O'Neill

Research output: Contribution to journalComment/debate

Original languageEnglish
JournalPLoS ONE
Volume8
Issue number2
DOIs
Publication statusPublished - 27 Feb 2013

Cite this

@article{ee539ce2ada047b1b428921d3566acfe,
title = "Correction: The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes (PLoS ONE)",
author = "Coll, {Rebecca C.} and O'Neill, {Luke A J}",
year = "2013",
month = "2",
day = "27",
doi = "10.1371/annotation/9f221489-155d-4978-a36d-30c51853e438",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science (PLOS)",
number = "2",

}

Correction : The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes (PLoS ONE). / Coll, Rebecca C.; O'Neill, Luke A J.

In: PLoS ONE, Vol. 8, No. 2, 27.02.2013.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Correction

T2 - The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes (PLoS ONE)

AU - Coll, Rebecca C.

AU - O'Neill, Luke A J

PY - 2013/2/27

Y1 - 2013/2/27

UR - http://www.scopus.com/inward/record.url?scp=84896533983&partnerID=8YFLogxK

U2 - 10.1371/annotation/9f221489-155d-4978-a36d-30c51853e438

DO - 10.1371/annotation/9f221489-155d-4978-a36d-30c51853e438

M3 - Comment/debate

AN - SCOPUS:84896533983

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

ER -